DETROIT – A non-invasive alternative to liver biopsy, now the
standard method of diagnosing cirrhosis in hepatitis patients, proved
very reliable in a national multi-center study including Henry Ford
The results of the study are good news for chronic hepatitis B and C
sufferers who now often undergo repeated and potentially painful liver
biopsies as part of their disease management.
Labels: cirrhosis, fibroscan, non-invasive tests